Who is sponsoring NCT03219684?

NCT03219684 is sponsored by Assiut University.

What drugs are being tested in NCT03219684?

Interventions in NCT03219684: serum protein ,kidney function ,liver function.,serum cholesterol.

What condition does NCT03219684 study?

NCT03219684 studies Steroid Dependent and Steroid Resistent Nephrotic Syndrome.

Is NCT03219684 still recruiting?

NCT03219684 is currently status unknown. Last updated 17 July 2017.

Last reviewed 2017-07-17 · How we verify

NCT03219684

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cyclosporin A Therapy in Childhood Nephrotic Syndrome

Status unknown Last updated 17 July 2017

What this trial tests

trial testing serum protein ,kidney function ,liver function.,serum cholesterol in Steroid Dependent and Steroid Resistent Nephrotic Syndrome in 50 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
1 April 2019

1 August 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 April 2018
Primary completion	1 April 2019
Estimated completion	1 August 2019

Drugs / interventions tested

serum protein ,kidney function ,liver function.,serum cholesterol

Conditions studied

Steroid Dependent and Steroid Resistent Nephrotic Syndrome — all drugs for Steroid Dependent and Steroid Resistent Nephrotic Syndrome →

Sponsor

Assiut University

Who can join

Adults 1 to 18, any sex, with Steroid Dependent and Steroid Resistent Nephrotic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nephrotic syndrome (NS) is among the most common pediatric kidney diseases and is defined as massive proteinuria (\>40 mg/m2/h or urine protein to creatinine ratio \>2 g/g) leading to hypoalbuminemia (\<2.5 g/dL), edema, and hyperlipidemia. 60-70 % of patients present prior to age of 6 years

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03219684 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 17 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03219684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing